NCT07530718 Body Composition Outcomes in MS Patients
| NCT ID | NCT07530718 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pennington Biomedical Research Center |
| Condition | Obesity |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-04-14 |
| Primary Completion | 2027-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2026-04-14 with a primary completion date of 2027-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Objectives The objective of this project is to generate pilot data substantiating our hypothesis that advanced body composition measurement tools will provide more accurate and clinically relevant data on the outcomes of metabolic surgery (MS) in patients with severe obesity compared to traditional methods. To achieve this objective, the investigators propose the following aims: Aim 1: Evaluate the effectiveness of different body composition measurement tools in assessing outcomes in patients with severe obesity undergoing MS. Aim 2: Assess the changes in body composition and muscle strength following MS. Aim 3: Compare body compositions changes between SG and RYGB patients.
Eligibility Criteria
Inclusion Criteria: * Being either male or female * Being an adult greater or equal to 18 years of age * BMI ≥40 kg/m2 * Weigh less than 440 pounds * Being willing to comply with the study procedures * Being scheduled for primary metabolic surgery (either Sleeve Gastrectomy or Roux-en-Y Gastric bypass) Exclusion Criteria: * Previous bariatric surgery or other complex abdominal surgery * Poorly controlled medical or psychiatric disorders * For women in child-bearing ages, being pregnant or attempting to become pregnant or currently breastfeeding * Having metal-containing objects in their body that may cause artifact on MRI * Having medical implants such as a pacemaker or metal joint replacements * Having a body weight greater than 440 pounds * Comorbid conditions that may affect body composition measurements, such as advanced liver disease or severe cardiovascular disease. * Cannot understand risks, benefits, and compliance required to participate.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07530718 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07530718 currently recruiting?
Yes, NCT07530718 is actively recruiting participants. Contact the research team at zubaidah.norhanipah@pbrc.edu for enrollment information.
Where is the NCT07530718 trial being conducted?
This trial is being conducted at Baton Rouge, United States, Baton Rouge, United States.
Who is sponsoring the NCT07530718 clinical trial?
NCT07530718 is sponsored by Pennington Biomedical Research Center. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.